ENGAGED 2 Study: Experiences With Mammography Screening and Breast Density 2
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 40 - 69 |
| Updated: | 9/30/2018 |
| Start Date: | February 15, 2017 |
| End Date: | August 2020 |
This trial will test a decision support web based intervention for women at increased risk
for breast cancer due to breast density and other risk factors (age, race/ethnicity, family
history of breast cancer, history of prior breast biopsies), and to consider MRI and/or
chemoprevention to manage their breast cancer risk.
for breast cancer due to breast density and other risk factors (age, race/ethnicity, family
history of breast cancer, history of prior breast biopsies), and to consider MRI and/or
chemoprevention to manage their breast cancer risk.
Along with better-known risk factors such as family history having dense breasts is one of
the strongest breast cancer risk factors. Extremely dense breast tissue affects about 10% of
women, with an additional third having heterogeneously dense breasts. Women in these
categories have 3-6 times the risk of breast cancer as compared to women with least density.
Although breast density is measured on routine screening mammograms, it is not typically
communicated to patients. This is changing as a result of legal mandates and approaches need
to be tested to effectively integrate this clinical information in care. Therefore,we have
developed an intervention to support decision making about cancer risk management (MRI and
chemoprevention) for women at clinically elevated risk using a web-based intervention that
will evaluate the efficacy of a web based intervention with personalized risk information
communication versus usual care.
the strongest breast cancer risk factors. Extremely dense breast tissue affects about 10% of
women, with an additional third having heterogeneously dense breasts. Women in these
categories have 3-6 times the risk of breast cancer as compared to women with least density.
Although breast density is measured on routine screening mammograms, it is not typically
communicated to patients. This is changing as a result of legal mandates and approaches need
to be tested to effectively integrate this clinical information in care. Therefore,we have
developed an intervention to support decision making about cancer risk management (MRI and
chemoprevention) for women at clinically elevated risk using a web-based intervention that
will evaluate the efficacy of a web based intervention with personalized risk information
communication versus usual care.
Inclusion Criteria:
- Women, aged 40-69
- Enrolled at Group Health
- Have had a negative mammogram as part of their routine care
- Either (a) an intermediate 5-year risk (>1.67%-2.49%) and extremely dense breasts or
(b) a high 5-year risk (≥2.50%) and either heterogeneously dense or extremely dense
breasts utilizing the Breast Cancer Surveillance Consortium Risk Calculator
(http://tools.bcsc-scc.org/BC5yearRisk/)
- Women must also have a valid email address.
Exclusion Criteria:
- Not able to speak and read English
- History of LCIS
- Prior cancer diagnosis (including DCIS)
- Known BRCA1/2 family mutation, or previous receipt of cancer genetic counseling
- Do not want to be contacted for research
- Have previously participated in intervention development activities
- Dis-enrolled from health plan between mammogram and start of recruitment.
We found this trial at
1
site
Seattle, Washington 28124
Phone: 206-287-2934
Click here to add this to my saved trials
